Literature DB >> 34493463

Measuring success in IVF is a complex multidisciplinary task: time for a consensus?

Laura Rienzi1, Danilo Cimadomo2, Alberto Vaiarelli2, Gianluca Gennarelli3, Jan Holte4, Claudia Livi5, Monica Aura Masip6, Petr Uher7, Gemma Fabozzi2, Filippo Maria Ubaldi2.   

Abstract

The goal of an IVF cycle is the birth of at least one baby per intention to treat. However, IVF cannot confer competence on an embryo, but only can provide each couple with a safe treatment to meet a predetermined chance of success. This commentary highlights how clinical, financial and patient-centred perspectives should be included in the definition of success in IVF. The primary outcome, which is the cumulative live birth delivery rate per intention to treat, must always be complemented by analyses of risks, costs and time invested, as well as by measures of patient satisfaction. Finally, it is essential, whenever clinical conditions exist, to limit treatment discontinuation after failed attempts. Constant monitoring of the data is pivotal and must be adjusted for patient characteristics and compared with national and international registers. The authors aimed to review all these aspects and highlight the points that are still open for discussion. Is it time for a consensus?
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Cost-effectiveness; Cumulative live birth rate; IVF success; Patient-centeredness; Time to pregnancy

Mesh:

Year:  2021        PMID: 34493463     DOI: 10.1016/j.rbmo.2021.08.012

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  2 in total

1.  Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A.

Authors:  Alberto Vaiarelli; Danilo Cimadomo; Gianluca Gennarelli; Maurizio Guido; Carlo Alviggi; Alessandro Conforti; Claudia Livi; Alberto Revelli; Silvia Colamaria; Cindy Argento; Maddalena Giuliani; Carlo De Angelis; Maria Matteo; Stefano Canosa; Angela D'Alfonso; Valentino Cimadomo; Laura Rienzi; Filippo Maria Ubaldi
Journal:  J Assist Reprod Genet       Date:  2022-02-07       Impact factor: 3.412

2.  Global inequality in sub-fertility treatment needs safer, cost effective, evidence-based and economically viable choices for patients and stakeholders.

Authors:  Gulam Bahadur; Roy Homburg; Asif Muneer; Paul Racich; Kanna Jayaprakasan; Santanu Acharya; Eric Jauniaux
Journal:  JBRA Assist Reprod       Date:  2022-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.